Major weight loss, pain relief seen with Eli Lilly's next-gen drug in late-stage trial Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of their body weight while reducing osteoarthritis pain. Orignial Source: https://www.foxbusiness.com/lifestyle/major-weight-loss-pain-relief-seen-eli-lillys-next-gen-drug-late-stage-trial Previous article: Disney announces major OpenAI deal, includes $1B equity investment, use of characters on Sora video platform Prev Next article: Abraham Accords allies may help US shift drug sourcing from China, report says Next
